Lankenau Medical Center Obstetrics and Gynecology

Topics

• Prenatal Screening and Diagnostics 53
• Endometrial and Cervical Cancer Treatments 48
• Pelvic floor disorders treatments 41
• Preterm Birth and Chorioamnionitis 30
• Ovarian function and disorders 27
• PARP inhibition in cancer therapy 23
• Assisted Reproductive Technology and Twin Pregnancy 22
• Ovarian cancer diagnosis and treatment 22
• Pregnancy and preeclampsia studies 22
• Endometriosis Research and Treatment 18
• Cervical Cancer and HPV Research 12
• Reproductive Biology and Fertility 11

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Bhavana Pothuri

2. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2023 · 360 citations · Bhavana Pothuri

3. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 148 citations · Bhavana Pothuri

4. Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

   Journal for immunotherapy of cancer · 2022 · 271 citations · Bhavana Pothuri

5. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 109 citations · Bhavana Pothuri